SYCP3 Antibody

What is SYCP3 and why is it important in meiosis research?

SYCP3 is an essential structural component of the synaptonemal complex, a proteinaceous structure required for proper chromosomal pairing and recombination during meiosis. It plays critical roles in:

• Synapsis, recombination, and segregation of meiotic chromosomes

• Centromere pairing during meiosis in male germ cells

• Supporting normal spermatogenesis and male fertility

• Female fertility, though to a lesser extent than in males

Human SYCP3 is a 236 amino acid protein with a molecular weight of approximately 28 kDa, containing a centrally located nuclear localization signal (NLS) and two C-terminal coiled-coil domains . These structural features are crucial for its function in synaptonemal complex assembly. Mutations in SYCP3 have been associated with azoospermia in males and susceptibility to pregnancy loss in females, highlighting its importance in reproductive biology .

What are the critical considerations when selecting SYCP3 antibodies for research applications?

When selecting SYCP3 antibodies, researchers should consider several factors:

For sensitive detection in applications like chromosome spreads, polyclonal antibodies (such as Bio-Techne's NB300-232 or Abcam's ab15093) often provide robust signals . For applications requiring high specificity with minimal background, monoclonal antibodies (like OriGene's TA336946) may be preferable . Always review validation data and published literature citing the antibody for your specific application before making a selection.

How should I optimize immunofluorescence protocols for SYCP3 detection in meiotic chromosome spreads?

For optimal SYCP3 visualization in meiotic chromosome spreads:

• Sample preparation:

  • Prepare fresh testicular or ovarian tissue

  • Create chromosome spreads using hypotonic treatment

  • Fix with 1% paraformaldehyde in PBS containing 0.1% Triton X-100

  • Air dry slides (can be stored at -80°C or used immediately)

• Blocking and antibody incubation:

  • Block with 3-5% BSA in PBS for 30-60 minutes at room temperature

  • Dilute primary anti-SYCP3 antibody in blocking solution (typically 1:100-1:500)

  • Incubate overnight at 4°C in a humid chamber

  • Wash thoroughly with PBS (3 × 5 minutes)

  • Apply fluorescently-labeled secondary antibody (1:200-1:500) for 1-2 hours at room temperature

  • Counterstain DNA with DAPI or Hoechst 33342

• Critical parameters:

  • Freshness of tissue significantly impacts staining quality

  • Hypotonic treatment duration affects chromosome spreading

  • Antibody concentration requires optimization for each sample type

  • Include known positive controls (e.g., normal adult testis sections)

This protocol has been validated with multiple antibodies including Abcam's ab15093, which has been cited in 211 publications, demonstrating reliable staining patterns of SYCP3 along the axes of paired chromosomes . Bio-Techne's NB300-232 has also been extensively validated for immunofluorescence applications and works at dilutions of 1:100-1:500 .

What are the best practices for optimizing Western blot detection of SYCP3?

For optimal Western blot detection of SYCP3:

• Sample preparation:

  • Use testicular tissue as a positive control (highest SYCP3 expression)

  • Extract proteins with RIPA buffer containing protease inhibitors

  • Denature samples at 95°C for 5 minutes in Laemmli buffer

• Gel electrophoresis and transfer:

  • Use 12-15% polyacrylamide gels (SYCP3 is ~28 kDa)

  • Transfer to PVDF membrane (preferred over nitrocellulose)

  • Verify transfer efficiency with reversible protein stain

• Antibody incubation:

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with primary antibody at optimized dilution:

    • Polyclonal antibodies: 1:500-1:3000 (e.g., Proteintech 30079-1-AP)

    • Monoclonal antibodies: 1:1000-1:8000 (e.g., Proteintech 66409-1-Ig)

  • Incubate overnight at 4°C with gentle agitation

  • Wash extensively with TBST (4 × 5 minutes)

  • Incubate with HRP-conjugated secondary antibody for 1 hour at room temperature

  • Detect using enhanced chemiluminescence

SYCP3 typically appears as a band at approximately 27-30 kDa . When troubleshooting, note that SYCP3 expression is highly tissue-specific, with strongest expression in testis and minimal expression in most somatic tissues. For reproductive research, Boster Bio's monoclonal antibody (M05718) has been validated specifically for Western blot applications with human samples .

How can SYCP3 antibodies be used to investigate meiotic defects in infertility research?

SYCP3 antibodies serve as powerful tools for investigating meiotic defects in infertility research through multiple approaches:

• Chromosome spread analysis:

  • Immunostaining with anti-SYCP3 antibodies reveals synaptonemal complex formation and structure

  • Co-staining with other meiotic markers (e.g., γH2AX, MLH1, BRCA1) provides comprehensive assessment of meiotic progression

  • Abnormal SYCP3 staining patterns may indicate defects in chromosome synapsis or recombination

• Genetic analysis correlation:

  • Characterize SYCP3 staining patterns in patients with known fertility issues

  • Correlate staining patterns with genetic variants in SYCP3 or other meiotic genes

  • Investigate protein-protein interactions affected by mutations

• Experimental approaches:

  • For C-terminal mutations (as found in recurrent pregnancy loss patients), express wild-type and mutant SYCP3 with differential tags (FLAG, T7)

  • Assess interaction capabilities through co-immunoprecipitation

  • Quantify relative binding affinity compared to wild-type/wild-type interactions

Research has shown that women with SYCP3 mutations experienced recurrent pregnancy loss, likely due to aneuploidy in embryos resulting from defective meiosis . When studying such mutations, immunoprecipitation experiments demonstrated that C-terminally truncated SYCP3 mutants interact with wild-type SYCP3, but with weaker affinity than wild-type/wild-type interactions . This compromised interaction may disrupt synaptonemal complex formation and lead to meiotic errors.

What experimental approaches can detect SYCP3 expression in cancer cells, and what might this expression signify?

SYCP3 expression in cancer cells is an intriguing phenomenon that can be investigated through several approaches:

• Detection methods:

  • Western blot analysis using validated antibodies (e.g., Proteintech's 30079-1-AP or 66409-1-Ig)

  • Immunohistochemistry on tissue microarrays to assess expression across tumor types

  • Flow cytometry for quantitative single-cell analysis using protocols validated for intracellular staining

  • RT-PCR or RNA-seq for transcript-level analysis

• Functional significance investigation:

  • Knockdown/knockout studies using siRNA or CRISPR-Cas9

  • Chromatin immunoprecipitation to identify DNA binding patterns

  • Co-immunoprecipitation to identify cancer-specific protein interactions

  • Cell cycle analysis to determine relationship between SYCP3 expression and cell cycle phases

• Potential significance:

  • Aberrant activation of meiotic programs in somatic cells

  • Contribution to genomic instability through effects on chromosome dynamics

  • Potential biomarker for certain cancer types or stages

  • Target for cancer-specific therapeutic approaches

Proteintech's antibodies (30079-1-AP and 66409-1-Ig) have been validated in human cancer cell lines, including DU 145 cells , making them suitable tools for investigating SYCP3 expression in cancer models. The functional significance of this expression remains an active area of research.

How can I troubleshoot inconsistent SYCP3 staining patterns in immunofluorescence applications?

When encountering inconsistent SYCP3 staining patterns, consider the following troubleshooting approaches:

• Sample preparation issues:

  • Fixation: Test different paraformaldehyde concentrations (0.5-2%)

  • Permeabilization: Adjust Triton X-100 concentration (0.1-0.5%) or try alternative permeabilization reagents

  • Antigen retrieval: Test citrate buffer (pH 6.0) heating for formalin-fixed samples

  • Blocking: Extend blocking time (1-2 hours) or increase blocking agent concentration (5% BSA)

• Antibody-related factors:

  • Concentration: Titrate primary antibody across a wider range (1:50-1:1000)

  • Incubation time: Extend to 48 hours at 4°C for challenging samples

  • Secondary antibody: Test different host species or fluorophores to reduce background

  • Antibody storage: Ensure proper aliquoting and storage conditions (-20°C, avoid freeze-thaw cycles)

• Technical considerations:

  • Microscopy: Optimize exposure settings and use appropriate filters

  • Mounting media: Use anti-fade reagents to prevent fluorescence quenching

  • Controls: Include positive controls (normal testis) and negative controls (primary antibody omission)

If the pattern varies between meiotic stages, this may reflect biological variation rather than technical issues. SYCP3 organization changes dramatically from leptotene (punctate) through pachytene (linear) to diplotene (fragmenting) .

What quality control measures should be implemented when using SYCP3 antibodies in critical research applications?

Implement these quality control measures when using SYCP3 antibodies for critical research:

• Validation experiments:

  • Positive controls: Include tissues with known SYCP3 expression (testis, fetal ovary)

  • Negative controls: Use tissues lacking SYCP3 expression (most somatic tissues)

  • Knockdown/knockout validation: Test antibody specificity using SYCP3-depleted samples

  • Peptide competition: Pre-incubate antibody with immunizing peptide to confirm specificity

• Documentation and reproducibility:

  • Record complete antibody information (manufacturer, catalog number, lot number, dilution)

  • Document all experimental conditions in detail

  • Include biological replicates (n≥3) and technical replicates

  • Use consistent image acquisition parameters for quantitative analyses

• Multi-method validation:

  • Confirm key findings with at least two antibodies from different sources

  • Validate protein expression with complementary techniques (e.g., Western blot to validate IF findings)

  • For novel applications, perform sequential dilution series to establish optimal concentration

For SYCP3 research specifically, Bio-Techne's NB300-232 and Abcam's ab15093 have extensive validation data across multiple species and applications , making them reliable choices for critical applications like meiotic chromosome analysis.

How can SYCP3 antibodies be used to study the effects of environmental toxins on meiotic progression?

SYCP3 antibodies provide valuable tools for investigating environmental toxin effects on meiosis:

Research using Bio-Techne's NB300-232 antibody demonstrated that exposure to DEHP (a common plasticizer) impairs meiotic progression of oocytes from pachytene to diplotene stages . The study used SYCP3 immunolabeling (red) with Hoechst 33342 (blue) counterstaining to visualize chromosome structure changes, allowing quantification of meiotic stage distribution following toxin exposure.

What are the most effective approaches for studying SYCP3 mutations and their effects on protein function?

To effectively study SYCP3 mutations and their functional impacts:

• Mutation identification and characterization:

  • Sequence SYCP3 in patient cohorts (especially those with fertility issues)

  • Perform in silico analysis to predict functional impacts

  • Create structural models based on known protein domains

• Functional analysis of mutations:

  • Express wild-type and mutant SYCP3 proteins with differential tags (FLAG, T7)

  • Conduct co-immunoprecipitation assays to assess protein-protein interactions

  • Perform immunofluorescence to evaluate protein localization and assembly

  • Use Western blotting to assess protein stability and expression levels

• Cellular models:

  • Transfect cultured cells with expression vectors containing WT or mutant SYCP3

  • Create CRISPR-Cas9 knock-in models of specific mutations

  • Analyze RNA splicing for intronic mutations using exon-trap vectors

Research on SYCP3 mutations in recurrent pregnancy loss patients revealed that C-terminal mutations affect the protein's ability to interact with wild-type SYCP3 . These findings were established through co-immunoprecipitation experiments using differentially tagged proteins (FLAG and T7). For intronic mutations potentially affecting splicing, researchers cloned genomic regions containing wild-type and mutant sequences into exon-trap vectors, which were then transfected into cells for RNA analysis . This approach effectively demonstrated splicing abnormalities resulting from intronic mutations.

What are the most reliable methods for quantifying SYCP3 immunofluorescence signals in meiotic chromosome studies?

For reliable quantification of SYCP3 immunofluorescence signals:

• Image acquisition considerations:

  • Use consistent microscope settings across all samples

  • Capture images below pixel saturation

  • Include internal controls in each imaging session

  • Collect Z-stacks for three-dimensional analysis of complex structures

• Quantification approaches:

  • Linear measurement: Assess synaptonemal complex length and continuity

  • Signal intensity: Measure SYCP3 fluorescence intensity along chromosome axes

  • Pattern analysis: Classify staining patterns (punctate, linear, fragmented)

  • Co-localization: Quantify overlap with other synaptonemal complex proteins

• Software tools and analysis:

  • ImageJ/Fiji with specialized plugins for chromosome analysis

  • CellProfiler for automated feature extraction

  • IMARIS for 3D reconstruction and analysis

  • Custom MATLAB scripts for complex pattern recognition

• Statistical analysis:

  • Use appropriate statistical tests based on data distribution

  • Include sufficient biological replicates (minimum n=3)

  • Account for cell-to-cell variability within samples

  • Consider non-parametric tests for meiotic staging data

When studying toxin effects on meiotic progression, researchers used SYCP3 antibodies to quantify the distribution of oocytes across meiotic stages, demonstrating significant shifts from pachytene to diplotene stages following DEHP exposure (p<0.05) . This quantitative approach enabled statistical validation of toxin-induced meiotic disruption.

How can multiplexed antibody approaches incorporate SYCP3 to comprehensively assess meiotic abnormalities?

Multiplexed antibody approaches with SYCP3 provide comprehensive meiotic assessment:

• Recommended antibody combinations:

  • SYCP3 + SYCP1: Distinguish between axial elements and transverse filaments

  • SYCP3 + γH2AX: Assess DNA damage response and XY body formation

  • SYCP3 + MLH1: Quantify crossover sites and distribution

  • SYCP3 + HORMAD1/2: Examine asynapsis and meiotic silencing

• Technical considerations:

  • Select primary antibodies from different host species (rabbit, mouse, goat)

  • Use highly cross-adsorbed secondary antibodies to prevent cross-reactivity

  • Employ sequential staining protocols for challenging combinations

  • Consider spectral imaging for complex multiplexing

• Analytical approaches:

  • Stage-specific analysis based on SYCP3 patterns

  • Co-localization quantification using specialized plugins

  • Distance measurement between different structures

  • Temporal progression analysis across meiotic substages

• Data integration:

  • Correlate findings across multiple markers

  • Create comprehensive profiles of meiotic abnormalities

  • Develop classification systems for meiotic defects

  • Integrate with genetic data for genotype-phenotype correlations

This approach has been successfully employed in studies of recurrent pregnancy loss, where SYCP3 mutations were associated with meiotic abnormalities . By combining SYCP3 with other markers, researchers can dissect the specific mechanisms by which mutations affect synaptonemal complex formation, homologous recombination, and chromosome segregation.

How might novel super-resolution microscopy techniques enhance SYCP3 research?

Super-resolution microscopy offers transformative capabilities for SYCP3 research:

• Applicable super-resolution techniques:

  • Structured Illumination Microscopy (SIM): 2× resolution improvement with conventional sample preparation

  • Stimulated Emission Depletion (STED): Up to 10× resolution improvement

  • Single-Molecule Localization Microscopy (STORM/PALM): Nanometer-scale precision

  • Expansion Microscopy: Physical sample expansion for enhanced resolution

• New biological insights enabled:

  • Nanoscale organization of SYCP3 within synaptonemal complex

  • Precise mapping of protein domains through antibody epitope localization

  • Quantitative analysis of SYCP3 clustering during synaptonemal complex assembly

  • Detailed visualization of SYCP3 interaction with chromatin loops

• Antibody considerations for super-resolution:

  • Higher specificity requirements due to enhanced resolution

  • Smaller probes (Fab fragments, nanobodies) for improved localization precision

  • Careful fixation optimization to preserve nanoscale structures

  • Specialized mounting media for specific techniques

• Challenges and solutions:

  • Photobleaching: Use oxygen scavenging systems and anti-fade reagents

  • Sample drift: Implement fiducial markers for drift correction

  • Chromatic aberration: Perform channel alignment with multicolor beads

  • Data analysis: Employ specialized software for super-resolution reconstruction

Super-resolution microscopy with SYCP3 antibodies can reveal previously undetectable structural abnormalities in patients with fertility issues, potentially identifying subtle defects that escape detection by conventional microscopy.

What is the potential for using SYCP3 antibodies in clinical diagnostics for reproductive medicine?

SYCP3 antibodies hold promising potential for clinical diagnostics in reproductive medicine:

• Diagnostic applications:

  • Evaluation of testicular biopsies from infertile men

  • Assessment of oocyte quality in assisted reproductive technologies

  • Genetic counseling for recurrent pregnancy loss

  • Screening for meiotic defects in cases of unexplained infertility

• Implementation considerations:

  • Standardization of protocols for clinical pathology

  • Development of scoring systems for abnormal SYCP3 patterns

  • Correlation with clinical outcomes

  • Integration with genetic testing data

• Technical requirements for clinical translation:

  • Highly validated antibodies with consistent lot-to-lot performance

  • Automated staining platforms for reproducibility

  • Digital pathology tools for quantitative assessment

  • Reference ranges for normal versus abnormal patterns

• Research gaps to address:

  • Prospective studies correlating SYCP3 abnormalities with reproductive outcomes

  • Establishment of diagnostic sensitivity and specificity

  • Cost-effectiveness analyses for clinical implementation

  • Development of simplified methods suitable for clinical laboratories

Table 1: Comparison of Commercial SYCP3 Antibodies and Their Applications